abstract |
The present invention relates to diazabicyclic compounds and, specifically, to compounds of formula (I), wherein A, G, R1, R R5, R6, and R7 are as defined in the specification. The compounds of formula (I) are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders. |